New FDA Guidance on 510(k) Transfer for Medical Devices

The FDA has published a much-needed draft guidance titled “Transfer of a Premarket Notification (510(k)) Clearance – Questions and Answers,” addressing the regulatory responsibilities when a 510(k) clearance is transferred or sold to a new entity.  

Key Highlights: 

1. Only One Recognized 510(k) Holder at a Time 
The FDA reaffirms that only one entity can be the legal 510(k) holder per device. The holder is the party introducing the device into interstate commerce. This eliminates confusion about shared or dual ownership and helps maintain regulatory accountability. 

2. No New 510(k) Required for Unchanged Devices 
If the device is transferred without significant changes to its design, components, manufacturing methods, or intended use, a new 510(k) submission is not required. However, the new holder must update device registration and listing under their name and use the original 510(k) number. 

3. Listing and Registration Must Be Updated Promptly 
The new 510(k) holder must: 

• Register their establishment via FDA’s FURLS/DRLM system within 30 days of initiating operations. 

• Update the device listing using the original FDA-assigned 510(k) number. 

• Ensure annual listing renewals reflect transferred products. 
  Failure to comply can result in the device being considered misbranded or adulterated. 

4. Labeling and UDI Obligations Transfer to New Holder 
The new labeler must: 

• Update the manufacturer/distributor name and address on product labeling as required by 21 CFR 801. 

• Ensure UDI data in GUDID reflects the new labeler information. 

• Meet UDI labeling requirements before commercial distribution resumes. 

5. FDA Will Not Manually Update 510(k) Ownership 
FDA will not accept notification emails or manual requests to update the 510(k) database. 
It is the responsibility of the new owner to: 

• Ensure correct registration and listing. 

• Retain or request documentation (e.g., prior 510(k) clearance letters). 

• Submit a FOIA request if documentation from the previous holder is unavailable. 

6. Applies to U.S. and Foreign Manufacturers 
Both domestic and foreign establishments acquiring a 510(k) clearance must meet these responsibilities. This includes: 

• Specification developers 

• Contract manufacturers 

• Repackagers 

• Relabelers 

• Importers (where applicable) 

Why Does This FDA 510(k) Transfer Guidance Matter

This document provides practical answers to frequently raised questions around 510(k) transfers. It enables smoother business transitions, enhances compliance, and strengthens FDA oversight by ensuring accurate registration and traceability of cleared medical devices. Public comments are open for 60 days. The deadline for submitting comments is August 4, 2025. 

How MedEnvoy Supports Your 510(k) Transfer Strategy 

At MedEnvoy, we offer end-to-end support for medical device companies navigating regulatory transitions including transfers in 510(k) ownership: 

• U.S. Agent Representation: For non-U.S. entities, we act as your designated U.S. Agent, ensuring timely communication with the FDA and guiding compliance with registration and listing obligations. 

• Regulatory Gap Assessments: We assess your device and labeling for any post-transfer updates required under FDA regulations, helping you avoid unintentional noncompliance. 

• Strategic Consulting: We advise on M&A transitions, licensing, and relabeling strategies that align with FDA’s expectations — from labeler responsibilities to UDI management. 

Whether you’re acquiring a portfolio, divesting a product line, or restructuring regulatory ownership — MedEnvoy can guide you through the complexities of FDA compliance with confidence. If you have any questions regarding this summary or the accompanying guidance document, we encourage you to reach out to our regulatory experts, here.

Please find the draft here: FDA Draft Guidance – Transfer of a Premarket Notification (510(k)) Clearance